Modern Retina | Ophthalmology News, Events & Expert Insights
WEBMerck and EyeBio announce initiation of phase 2b/3 BRUNELLO trial evaluating MK-3000 for DME. By Martin David Harp. September 6th 2024. MK-3000, formally known as EYE103, is an investigational, potentially first-in-class tetravalent, tri-specific antibody that acts as an agonist of the Wnt signaling pathway.
Tackling teleretinal screening for diabetic retinopathy - Modern …
WEBNov 4, 2021 · Diabetic retinopathy (DR) is the leading cause of permanent blindness in working-age adults, and the number of patients with diabetes worldwide is expected to reach 693 million by 2045. 1 Consequently, it is necessary to find a more effective means of screening patients for diabetic retinopathy. 2 A viable testing option is teleretinal screening for diabetic retinopathy (TSDR), a technology ...
Retinal exam brings diabetic retinopathy screening to primary …
WEBMay 1, 2016 · Retinal exam brings diabetic retinopathy screening to primary-care setting. A retinal exam system improves access for patients with diabetes to detect eye disease early and refers them to an eye-care specialist for further evaluation and treatment. Take-home message: A retinal exam system improves access for patients with diabetes to detect eye ...
Latest Conference Articles - Modern Retina
WEBWIO 2024: A conversation with WIO President, Christina Y. Weng, MD, MBA. August 22nd 2024. WIO. Christina Y. Weng, MD, MBA discussed what attendees, both virtually and in-person, can expect from this year's Women in Ophthalmology Summer Symposium meeting in Carlsbad, California. The meeting will take place August 22-25, 2024.
Diagnosing and treating MacTel degenerative retinal disease
WEBAug 1, 2017 · Idiopathic macular telangiectasia (MacTel) is a degenerative retinal disease that was described by Gass and Oyakawa in 1982. 1. Later, Gass and Blodi identified three subtypes of the disease. 2 In 2006, Yannuzzi et al. proposed a classification that is commonly used: aneurysmal (type 1), perifoveal (type 2) and occlusive (type 3). 3 Type 1 ...
Zilia receives FDA clearance for retinal camera - Modern Retina
WEBNov 30, 2023 · Zilia, a medical technology company specializing in the non-invasive assessment of ocular biomarkers, this week announced it has received FDA clearance for its Zilia Ocular FC retinal camera. Based in Quebec City, Canada, Zilia’s Ocular FC system is designed for assessing ocular biomarkers. 1 …
Medication-induced retinal toxicity: How risk awareness can help
WEBMar 24, 2021 · In addition, the daily dose should not exceed 400 mg and ideally should be just 200 mg. “Most reports of toxicity have occurred in patients on medication for greater than 7 years or having received a total dose of at least 460 g,” Mieler said. “High dosages hasten the accumulation of drug and may enhance the degree of tissue damage.
LEAD Study: Reducing AMD Progression Rates with Subthresold …
WEBOct 5, 2023 · Reviewed by Robyn Guymer, MBBS, PhD. Investigators from the LEAD Study reported that subthreshold nanosecond laser (SNL) may reduce the rate of progression to late age-related macular degeneration (AMD) as long as …
NR600 retinal prosthesis: Safe with promising visual results
WEBOct 2, 2020 · The NR600 is a stand-alone implant without wires that traverse the eye wall. Dr Stalmans explained that the device uses the natural eye optics and the retinal natural signal processing to provide the patient with vision. In this study, a miniature chip was implanted in the retina and held in place in the sulcus with haptics resembling those of ...
Satellite clinics and other strategies to enhance rural ophthalmology
WEBJun 18, 2024 · Subspecialist ophthalmologists in rural areas face unique geographical challenges that often require innovative approaches to providing patient care. Proactive communication with referring doctors and maximizing efficiency of patient visits are essential pillars of success, ultimately enhancing the …